Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Risk factors and incidence of surgical wound infection after stoma reversal: A systematic review and meta-analysis

  • Siruo Li ,

    Contributed equally to this work with: Siruo Li, Ziyi Zhou

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Resources, Software, Writing – original draft, Writing – review & editing

    Affiliation Zhejiang University, Hangzhou City, Zhejiang Province, China

  • Ziyi Zhou ,

    Contributed equally to this work with: Siruo Li, Ziyi Zhou

    Roles Conceptualization, Data curation, Formal analysis, Methodology, Resources, Software, Writing – original draft, Writing – review & editing

    Affiliation Zhejiang University, Hangzhou City, Zhejiang Province, China

  • Feixia Wang ,

    Roles Conceptualization, Data curation, Project administration, Resources, Supervision, Writing – review & editing

    1299038@zju.edu.cn

    Affiliation Department of Nursing, The First Affiliated Hospital of Zhejiang University, Hangzhou City, Zhejiang Province, China

  • Weizhen Li,

    Roles Formal analysis, Methodology, Software, Validation, Writing – review & editing

    Affiliation Department of Nursing, The First Affiliated Hospital of Zhejiang University, Hangzhou City, Zhejiang Province, China

  • Chaoxu Liu,

    Roles Methodology, Software, Validation, Writing – review & editing

    Affiliation Department of Colorectal Surgery, The First Affiliated Hospital of Zhejiang University, Hangzhou City, Zhejiang Province, China

  • Lu Li

    Roles Methodology, Resources, Software, Writing – review & editing

    Affiliation Department of Nursing, The First Affiliated Hospital of Zhejiang University, Hangzhou City, Zhejiang Province, China

Correction

11 Nov 2025: Li S, Zhou Z, Wang F, Li W, Liu C, et al. (2025) Correction: Risk factors and incidence of surgical wound infection after stoma reversal: A systematic review and meta-analysis. PLOS ONE 20(11): e0336704. https://doi.org/10.1371/journal.pone.0336704 View correction

Abstract

To determine the incidence and risk factors of incisional infection following stoma reversal surgery. As of July 30, 2024, an extensive literature search was conducted on databases including PubMed, Web of Science, Cochrane, Embase, and OpenGrey. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. Data analysis was performed using Stata 14.0.20 articles were included, with a total sample size of 8542, including 723 patients with incision infection. The incidence of incision infection was 12%(95%CI:0.094–0.145). The results identified 5 patient-related risk factors of incisional infection, including stoma type (OR: 3.06, P = 0.015), inflammatory bowel disease (OR: 1.91, P = 0.012), Body Mass Index (BMI; OR: 1.12, P < 0.01), period from stoma creation (OR: 0.18, P = 0.012), and surgical site infection (SSI) after primary surgery (OR: 3.57, P < 0.01), and 3 surgery-related risk factors, including subcutaneous drainage (OR: 0.26, P = 0.019), suture method (OR: 4.83, P < 0.01), operation time > 60 min (OR: 4.33, P < 0.01), operation time (continuous variable, OR: 1.004, P < 0.01). Clinical staff can refer to the influential factors in this study to reduce the incidence of incision infection.

Introduction

Ostomy is one of the common treatment modalities for colorectal cancer, diverticular disease, and inflammatory bowel disease, especially colorectal cancer. The temporary stoma plays a role in diverting feces and reducing anastomotic contamination. It can reduce the severity of postoperative complications and mortality rate [1]. 3 to 6 months following ostomy, patients undergo stoma reversal to return the bowel and restore physiologic excretory access. With the rising incidence of colorectal cancer, the number of patients undergoing temporary stoma and stoma reversal is also increasing [2]. The complication rate of stoma reversal is high, ranging from 6.7% to 40%, of which SSI is the most common complication [35].

The reported incidence of SSI after stoma reversal varies widely. The incidence of wound infection after stoma reversal ranges from 2–41% due to peristomal skin complications resulting in compromised skin integrity and colonization by pathogenic microorganisms [6,7]. SSI will not only delay the speed of incision healing, but also further develop into incision dehiscence, incisional hernia, and even septic shock. At the same time, it will also prolong the hospitalization time of patients, increase the readmission rate and the rate of secondary surgery, and increase the social medical burden [1,8]. Early detection of high-risk patients and prompt intervention are key to lowering the incidence of SSI [9].

It has been shown that BMI affects the incidence of SSI after stoma reversal [10]. However, another study found that BMI was not an influencing factor [3]. Given the conflicting findings and the small sample size of individual studies, a meta-analysis is necessary to assess the results of the current study fully. Therefore, this study aims to investigate the incidence of SSI after stoma reversal and to identify the risk factors influencing SSI after stoma reversal.

Methods

Literature search

The search strategy and process of this study were reported according to PRISMA 2020 [11], the reporting specification guide for systematic evaluation and Meta-analysis. Our research was preregistered with PROSPERO(ID: CRD42023449934).

From the inception of the database to July 30, 2024, 2 researchers independently and comprehensively searched PubMed, Web of Science, Cochrane, and Embase for English-language studies. Additionally, the English language literature of OpenGrey, a gray literature database, was searched from the beginning of the database to January 6, 2025. The search terms were as follows:(‘ileostomy’, ‘colostomy’, ‘ostomy’, ‘loop ileostomy’, ‘diverting ileostomy’, ‘surgical stomas’, ‘stoma’); (‘closure’, ‘reversal’); (‘complications’, ‘morbidity’); (‘surgical wound infection’, ‘Surgical Wound Infection’, ‘Surgical Site Infection’, ‘Postoperative Wound Infection’, ‘SSI’); (‘Risk Factor*’, ‘Influencing Factor*’, ‘predictor’). The search strategy for all databases was presented in S 1 File. In addition, references to included studies were manually searched for other relevant articles that were not captured by the initial search.

Inclusion and exclusion criteria

Inclusion criteria: ① Study type: cross-sectional study, retrospective or prospective cohort study, case-control study; ② Patient characteristics: patients ≥18 years of age who have undergone stoma reversal surgery;③ The study reported the influencing factors of incision infection after stoma reversal and the corresponding OR or RR values and 95% CI values, ④ Literature type: Conference papers, academic papers.

Exclusion criteria: ① Articles for which full text is unavailable;② Reviews, study protocols, letters, animal experiments, and case reports;③ Studies with insufficient data.

Diagnostic criteria

Diagnostic criteria for surgical incision infections refer to the Centers for Disease Control and Prevention [12]. Surgical incision infections include superficial incision infections, deep incision infections, and organ infections. Superficial incision infections occur in the skin and subcutaneous tissue within 30 days of surgery. Deep incision infection is a surgical-related infection involving deep soft tissue (deep fascia and muscle) of the incision within 30 days after implant-free surgery and within 1 year after implant surgery (such as artificial heart valves, artificial blood vessels, mechanical hearts, and artificial joints).

Ethical statement

This study is a systematic review and meta-analysis, and ethical statements are not suitable.

Data extraction

2 independent reviewers (Siruo Li; Ziyi Zhou) screened the abstracts of all identified studies using Endnote. Studies that were likely to be included in the review would be obtained in full-text form and assessed by the same reviewers (Siruo Li; Ziyi Zhou). Any disagreements at any stage of study selection would be resolved by consensus or referral to a third reviewer (Weizhen Li). Reasons for rejection at the full-text screening stage will be presented in S1 File. Data for inclusion in the literature of this study were extracted by two researchers (Siruo Li; Ziyi Zhou) and organized using Excel. The extracted data included: first author, publication year, country, study year, sex, sample size, infection rate, follow-up time, study design, risk factors, and Newcastle-Ottawa scale (NOS) score.

Quality assessment

The quality of the screened articles was evaluated by two independent researchers. The Newcastle-Ottawa Quality Assessment Scale (NOS) was used to rate the quality of literature included in the cohort and case-control studies, with a score of 1–3 as low-quality literature, 4–6 as moderate-quality literature, and 7–9 as higher-quality literature [13]. The American Agency for Healthcare Quality and Research (AHRQ) Criteria for Evaluating the Quality of Cross-Sectional Studies was used to score cross-sectional studies, with a score of 0–3 as low-quality literature, a score of 4–7 as moderate-quality literature, and a score of 8–11 as higher-quality literature [14]. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) has been used to rate the overall certainty or quality of evidence for each of the pooled risk factors, and categorized them as either “high,” “moderate,” “low,” or “very low” (S1 File) [15]. Consensus was reached for final inclusion of the studies, and if there was disagreement the decision to include was left to the judgment of a third party.

Statistical analysis

Stata14.0 was used to conduct the meta-analysis. Using the 95% credible interval (95% CI) and odds ratio (OR), the influencing factors were pooled to create effect sizes. The degree of heterogeneity was evaluated using the I2 test; if P > 0.1, I2 < 50%, there was no heterogeneity, and a fixed-effects model was employed; if P < 0.1, I2 > 50%, there was significant heterogeneity, and a random-effects model was used, along with sensitivity analysis or subgroup analysis. For SSI after stoma reversal incidence subgroup analysis of stoma type was performed. Publication bias analysis was performed when ≥10 papers were included.

Results

Study selection

The initial search of the database yielded 1598 documents, and 715 documents were obtained after eliminating duplicate publications. Following reading the titles and abstracts, 100 documents were obtained and assessed at the full text, and 20 of these were included after full-text reading (Fig 1).

Study characteristics

Characteristics of the 20 retained studies are presented in Table 1. A total sample size of 8542 cases were enrolled in the studies and 723 patients with incisional infections were finally included. Among the studies included, the most common country of origin was the USA(n = 7), the remaining studies were conducted in Australia (n = 3), Germany (n = 1), Mexico (n = 1), and 8 studies from Asia. 32 potential risk factors were extracted for analysis.

Quality assessment

The quality of the literature included was generally high, with 8 studies being of high quality and 12 of moderate quality (Table 1). The NOS average score was 6.3.

The overall incidence of SR-SSI(Stoma Reversal-Surgical Site Infection)

Meta-analysis was performed on the 20 included studies. The results showed that the incidence of SR-SSI was 12%(95% CI:9%−15%, I2 = 95.28%), as shown in Fig 2.

thumbnail
Fig 2. The overall incidence of incisional infections after stoma reversal surgery.

https://doi.org/10.1371/journal.pone.0328344.g002

Risk factors

32 risk factors were extracted from the 20 included studies, of which 15 were meta-analyzed. The remaining 17 could not be meta-analyzed. Of these 17 risk factors, age, antibiotics prophylactic, and skin anastomoses were not quantitatively analyzed due to inconsistent definitions that would have generated errors. The remaining 14 risk factors were all reported in only 1 study and could not be quantitatively analyzed. The results of the meta-analysis can be seen in Table 2.

thumbnail
Table 2. Summary of risk factors for surgical site infection after stoma reversal surgery.

https://doi.org/10.1371/journal.pone.0328344.t002

Patient-related risk factors

Stoma type.

Five articles [10,18,23,26,32] comparing ileostomies with colostomies found that the type of stoma can have an impact on SR-SSI (OR: 3.06, 95% CI: 1.25–7.52, P = 0.015, I2 = 58.5%, Fig 3; GRADE assessment: very low).

Inflammatory bowel diseas.

A meta-analysis of three studies [3,26,30] showed that it would increase the risk of SSI when the underlying disease is inflammatory bowel disease (OR: 1.91, 95% CI: 1.15–3.17, P = 0.012, I2 = 0; Fig 4; GRADE assessment: low).

Period from stoma creation.

Four studies reported periods from stoma creation, two of which defined [24,31] this factor as a categorical variable and the other two as a continuous variable. The results showed that the period from stoma creation (categorical variable) had a relationship with SSI (OR: 0.18,95% CI: 0.05–0.68, P = 0.012, I2 = 0; Fig 5; GRADE assessment: low). A meta-analysis of two studies [19,28] found that the period from stoma creation (continuous variable) had no relationship with SSI (OR: 1.04,95% CI: 0.15–7.39, P = 0.97, I2 = 97%, Fig 6; GRADE assessment: very low).

BMI.

Five studies reported BMI, three of which [3,10,17] took BMI ≥ 25 kg/m2 (OR: 1.78, 95% CI: 0.82–3.86, P < 0.15, I2 = 70.6%; Fig 7; GRADE assessment: very low). It had no effect on the occurrence of SSI. The other two papers [22,29] defined BMI as a continuous variable, at which point the results indicated that BMI had an impact on SSI (OR: 1.12, 95% CI: 1.08–1.16, P < 0.01, I2 = 20.4%; Fig 8; GRADE assessment: low).

Surgical site infection after primary surgery.

A meta-analysis of two studies [16,24] found that surgical site infection after primary surgery had a significant relationship with SSI (OR: 3.57,95% CI: 1.63–7.82, P < 0.01, I2 = 0; Fig 9; GRADE assessment: low).

Subcutaneous fat thickness.

A meta-analysis of two studies [23,24] found that subcutaneous fat thickness had no relationship with SSI (OR: 3.91,95% CI: 0.97–15.85, P = 0.06, I2 = 87.4; Fig 10; GRADE assessment: very low).

History of fascia cracking.

The meta-analysis of two studies [23,26] found that history of fascia cracking had no relationship with SSI (OR: 3.92,95% CI: 0.50–30.94, P = 0.20, I2 = 57.6; Fig 11; GRADE assessment: very low).

Cancer.

The meta-analysis of two studies [3,26] found that cancer had no relationship with SSI (OR: 1.08,95% CI: 0.60–1.95, P = 0.80, I2 = 0; Fig 12; GRADE assessment: low).

Diverticulosis.

The meta-analysis of two studies [3,30] found that diverticulosis had no relationship with SSI (OR: 2.09,95% CI: 0.22–19.57, P = 0.52, I2 = 84.5; Fig 13; GRADE assessment: very low).

Smoke.

The meta-analysis of five studies [6,17,20,24,26] found that smoke had no relationship with SSI (OR: 1.55,95% CI: 0.67–3.56, P = 0.31, I2 = 68.7; Fig 14; GRADE assessment: very low).

Gender.

The meta-analysis of four studies [3,16,19,24] found that gender had no relationship with SSI (OR: 1.25,95% CI: 0.41–3.80, P = 0.69, I2 = 74.4; Fig 15; GRADE assessment: very low).

Surgery-related risk factors

Subcutaneous drainage.

Three studies [24,26,27] reported subcutaneous drainage may affect SR-SSI. This study found that subcutaneous drainage was a protective factor. It can reduce the incidence of SR-SSI (OR: 0.26, 95% CI: 0.09–0.90, P = 0.019, I2 = 50.4%; Fig 16; GRADE assessment: low).

Suture method.

A total of six studies [6,10,17,21,22,24] revealed that the suturing method may have an impact on the occurrence of SSI. The results found that purse closure was related to SR-SSI (OR: 4.83, 95% CI: 2.83–8.26, P < 0.01, I2 = 0%; Fig 17; GRADE assessment: low).

Operation time.

Five studies found that operation time may influence SSI incidence. Increased surgical duration elevated the risk of incidence of SR-SSI. Two papers [3,30] defined the operation time as a continuous variable and showed that it had a relationship with the occurrence of SSI (OR: 1.004, 95% CI: 1.002–1.007, P < 0.01, I2 = 38.6%; Fig 18; GRADE assessment: very low). Three papers [20,27,28] defined the operation time as a categorical variable, and the results showed that when the operation time was longer than 60 minutes it increased the risk of SSI (OR: 4.33, 95% CI: 2.92–6.44, P < 0.01, I2 = 0%; Fig 19; GRADE assessment: low).

Incision type.

The meta-analysis of two studies [25,26] found that incision type had no relationship with SSI (OR: 2.80, 95% CI: 0.80–9.85, P = 0.11, I2 = 49.9; Fig 20; GRADE assessment: very low).

Sensitivity analysis results

Sensitivity analyses of the incidence of SR-SSI were robust (S1 File). There was significant heterogeneity in both subcutaneous drainage (I2 = 50.4%) and stoma type (I2 = 58.5%), and sensitivity analysis for the items showed stable results for subcutaneous drainage and stoma type (S1 File). The heterogeneity of subcutaneous drainage may be related to the different methods of drainage, with 1 study investigated with a silicone duct connected to a squeezable, vacuum reservoir [27], and 1 used gauze [22], the other didn’t mention the specific way of drainage due to its study design [26]. The heterogeneity of stoma types may be due to the fact that one study adopted a closed suction drain and subcutaneous large-bite buried suture technique to reduce the incidence of SSI [32]. We performed sensitivity analyses for subcutaneous fat thickness, diverticulosis, and gender, and the results were robust (S1 File).

Subgroup analysis and publication bias

A subgroup analysis of SR-SSI incidence was performed to investigate the effect of stoma type on SR-SSI incidence (S1 File). The results showed that the incidence of SR-SSI was higher in patients with colostomy. Publication bias analysis was performed on the incidence of SR-SSI, and the results can be seen in S1 File Egger publication bias test P = 0.008, which indicates some publication bias.

Discussion

SSI is a common complication that can occur after stoma reversal, leading to negative outcomes such as prolonged hospitalization and surgical failure. While numerous influencing factors have been reported in the literature, the findings are often complex and inconsistent. Crucially, a comprehensive and systematic synthesis of these risk factors specifically for SR-SSI is lacking, and the true impact of many proposed factors remains unclear. This knowledge gap has hindered progress in both understanding the etiology and developing effective prevention strategies for SR-SSI. To address this critical need, our study undertakes a rigorous and comprehensive examination of the contributing factors for SR-SSI. The primary contribution of this work lies in its systematic integration and critical evaluation of the existing, often conflicting, evidence, providing a clearer and more consolidated picture of the key risk factors associated with SR-SSI. This foundational synthesis clarifies the current landscape and establishes a solid basis for future research and targeted clinical interventions.

The overall incidence of SR-SSI

The incidence of SSI in this study was 12%, which aligns with other literature reports ranging from 0% to 33% [3335]. This incidence with high heterogeneity is in the lower middle range. This may be related to differences in study design, diagnostic guidelines between regions, and level of care. The incidence of SSI in colorectal surgery in the United States is 1–3% [8], and the incidence of SSI in colorectal surgery in China is 5.6% [36]. The rate of SSI reported in this study is much higher than in other abdominal surgeries. In addition, being a second-stage procedure in a short period of time, susceptible to infection, as well as taking into account enteric nutrition, stoma reversal has special characteristics. This calls for increased attention to SSI after stoma reversal. We believe that our study will not only increase the attention of researchers to the complications of SSI after stoma reversal but also help clinicians to identify high-risk patients and take early interventions to prevent postoperative SSI, thereby reducing healthcare costs and improving patient outcomes.

Risk factors

Postoperative drainage has been found to reduce the risk of infection, as demonstrated by the pooled results of the study. This is consistent with the results of Zhu et al. [37]. Commonly used clinical drainage materials include sterile silicone hose or sterile gauze. These materials enable the one-way flow of fluid through gravity or osmotic pressure, effectively flushing the area and reducing local pressure. However, there is no comparison of the effect of the two materials on the postoperative healing time of the incision. It is more of an intraoperative judgment of the amount of local fluid, and there is no uniform judgment standard. As for the suture method, linear sutures are associated with a nearly 5-fold increased risk of SSI compared with purse-string sutures. The purse-string suture with a hole in the middle can facilitate the timely drainage of the wounds. McCartan et al. [38] thus suggested that this method results in the presence of open wounds for a prolonged time, which may negatively affect the quality of life of the patient. However, Rondelli et al. [39] found that the length of patient hospitalization was not affected by the suture approach and that the total length of hospitalization could be lower than one-stage sutures due to the lower incidence of SSIs with purse-string sutures. This suggests that clinical practitioners should take a holistic approach when choosing sutures to benefit their patients.

Colostomy is considered a risk factor for SSI. The higher chance of incision infection after colostomy reversal compared to ileostomy reversal is consistent with the results of an earlier meta-analysis by Tilney et al. [40]. This may be related to the high bacterial load at the colonic site. In addition, colostomy reversal is more difficult than ileostomy reversal. The colon is characterized by a thinner intestinal wall and poorer blood supply, making the procedure relatively more difficult and longer, and the longer the procedure, the higher the chance of infection. Therefore, it is important to intervene in patients undergoing colostomy rejuvenation and to monitor the patient’s incision healing for early detection of signs of infection.

A study shows patients with inflammatory bowel illness have a greater incidence of SSI [41]. This aligns with the findings of the current investigation. As demonstrated by Mansfield et al. [42], the incidence of SSI in patients with inflammatory bowel disease is influenced by nutritional state and the use of hormone medicines. Hormonal therapy is a common treatment for people with inflammatory bowel disease, and it suppresses the patients’ immune systems. In addition, the patient may have pre-existing peritonitis and have low nutritional status as a result of the condition, both of which hinder the healing of the incision after surgery. Therefore, we need to pay special attention to patients with inflammatory bowel disease who undergo stoma reversal and take measures to prevent SSI.

Stoma reversal is typically performed 3–6 months after stoma surgery, but there is no clinical consensus on this interval. We found that incisional infection after stoma reversal decreased with increasing reversal interval. Early stoma reversal is safe, feasible, and reduces stoma-related complications, according to O’Sullivan et al. [43]. However, it increases postoperative complications, particularly incisional complications, possibly due to the patient’s abdominal cavity remaining adherent after one-stage surgery and stoma edema and inflammation. Ng et al. [44] showed no difference in the anastomotic leak or hospitalization between early and late stoma reversal, but early reversal increased SSI while late reversal increased stoma complications and worsened quality of life, aligning with our results. Although some guidelines support early reversal [45], some researchers favor late reversal for patients with temporary ileostomy for rectal cancer [46]. The timing of stoma reversal requires further large-scale studies to explore early versus late indications, impact on quality of life, postoperative complications, and other aspects of stoma reversal.

BMI is generally recognized as a risk factor for SSI development. According to the Cochrane Handbook recommendations, subgrouping and reducing heterogeneity when the types of original study variables are inconsistent [47]. Therefore, in this study, BMI was divided into continuous type variables and subtype variables for combined analysis. While BMI ≥ 25 kg/m2 was not statistically significant in the present study, data related to its continuous type variables were statistically significant. BMI ≥ 25 kg/m2 is a risk factor for incisional hernia after stoma reversal, but it is not clear whether this influence has an impact on postoperative incisional infection [48]. Gurunathan et al. [49] found the risk of postoperative incisional infection was 20% versus 50% higher in patients with BMI ≥ 25 kg/m2 versus BMI ≥ 30 kg/m2, consistent with this study’s results. This results in reduced blood and oxygen supply and delayed tissue regeneration. These patients also have inefficient metabolic regulation and a high inflammatory cascade, predisposing to incisional infection [50]. Some relevant studies have shown that BMI does not fully reflect body fat distribution, and that subcutaneous fat thickness is a better predictor of postoperative SSI in abdominal surgeries than BMI [51]. Fujii et al. [52] found subcutaneous fat thickness was the most valuable predictor of postoperative SSI in colorectal surgeries. The present study included two papers on the association of subcutaneous fat thickness with SSI incidence, with pooled results showing no statistical significance and high heterogeneity (I2 = 87.4%), possibly related to different study types. Future studies could further explore this factor’s effect on SSI.

This study found that the history of incisional infection after the initial (phase I) procedure impacts the development of incisional infection after stoma reversal. It is likely due to residual postoperative colonization with pathogenic microorganisms and susceptibility to pathogens. The specific mechanism by which a history of incisional infection after phase I surgery influences incisional infection after stoma reversal remains unknown; further relevant studies are needed [14,24]. The risk factors identified in our study can help us construct effective intervention programs, identify high-risk patients early, link the perioperative period of primary surgery to the perioperative period of stoma reversal, and drive the timing of prevention forward. In addition, the studies included in this article did not report risk factors such as diabetes, and we will further update the review to refine the factors influencing SR-SSI.

Limitations

Although our study cannot clarify the causal relationship between the influencing factors and infection, it may provide a basis for subsequent prospective large cohort studies. Most studies included in this review were retrospective with weak arguments; larger, multicenter, prospective studies are needed. Inconsistent definitions of influencing factors and variable types across studies led to heterogeneity. Some influencing factors appeared in only two papers, limiting reliability and generalizability. Additionally, the data for the incidence of our study were all taken from the literature included in this paper, and data from other studies were not included, which may have had an impact.

Conclusions

In summary, subcutaneous drainage, purse string closure, stoma type, inflammatory bowel disease, operative time, interval from stoma creation, BMI, and surgical site infection after primary surgery are influencing factors for after stoma reversal. Healthcare providers and policymakers can reduce the incidence of SR-SSI by increasing awareness of these risk factors, controlling modifiable risk variables, and developing effective intervention programs.

Trial and protocol registration

Our protocol is registered with PROSPERO(ID: CRD42023449934) https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=449934.

References

  1. 1. Sherman KL, Wexner SD. Considerations in stoma reversal. Clin Colon Rectal Surg. 2017;30(3):172–7.
  2. 2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
  3. 3. de Paula TR, Nemeth S, Kiran RP, Keller DS. Predictors of complications from stoma closure in elective colorectal surgery: an assessment from the American College of Surgeons National Surgical Quality Improvement Program (ACSNSQIP). Tech Coloproctol. 2020;24(11):1169–77. pmid:32696174
  4. 4. Goret NE, Goret CC, Cetin K, Agachan AF. Evaluation of risk factors for complications after colostomy closure. Ann Ital Chir. 2019;90:324–9.
  5. 5. Rubio-Perez I, Leon M, Pastor D, Diaz Dominguez J, Cantero R. Increased postoperative complications after protective ileostomy closure delay: An institutional study. World J Gastrointest Surg. 2014;6(9):169–74.
  6. 6. Yamamoto M, Tanaka K, Masubuchi S, Ishii M, Hamamoto H, Suzuki S, et al. Risk factors for surgical site infection after stoma closure comparison between pursestring wound closure and conventional linear wound closure: Propensity score matching analysis. Am J Surg. 2018;215(1):58–61. pmid:29029780
  7. 7. Harold DM, Johnson EK, Rizzo JA, Steele SR. Primary closure of stoma site wounds after ostomy takedown. Am J Surg. 2010;199(5):621–4. pmid:20466105
  8. 8. Mahmoud NN, Turpin RS, Yang G, Saunders WB. Impact of surgical site infections on length of stay and costs in selected colorectal procedures. Surg Infect (Larchmt). 2009;10(6):539–44. pmid:19708769
  9. 9. Meeks DW, Lally KP, Carrick MM, Lew DF, Thomas EJ, Doyle PD. Compliance with guidelines to prevent surgical site infections: as simple as 1-2-3? Am J Surg. 2011;201(1):76–83.
  10. 10. Mirbagheri N, Dark J, Skinner S. Factors predicting stomal wound closure infection rates. Tech Coloproctol. 2013;17(2):215–20. pmid:23076288
  11. 11. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  12. 12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. pmid:18538699
  13. 13. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. pmid:20652370
  14. 14. Chou R, Baker WL, Bañez LL, Iyer S, Myers ER, Newberry S. Agency for healthcare research and quality evidence-based practice center methods provide guidance on prioritization and selection of harms in systematic reviews. J Clin Epidemiol. 2018;98:98–104.
  15. 15. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–94. pmid:21195583
  16. 16. Akiyoshi T, Fujimoto Y, Konishi T, Kuroyanagi H, Ueno M, Oya M, et al. Complications of loop ileostomy closure in patients with rectal tumor. World J Surg. 2010;34(8):1937–42. pmid:20372898
  17. 17. Suh YJ, Park JW, Kim YS, Park SC, Oh JH. A beneficial effect of purse-string skin closure after ileostomy takedown: a retrospective cohort study. Int J Surg. 2014;12(6):615–20. pmid:24810869
  18. 18. Kobayashi S, Ito M, Sugito M, Kobayashi A, Nishizawa Y, Saito N. Association between incisional surgical site infection and the type of skin closure after stoma closure. Surg Today. 2011;41(7):941–5. pmid:21748610
  19. 19. Cribb B, Kollias V, Hawkins R, Ganguly T, Edwards S, Hewett P. Increased risk of complications in smokers undergoing reversal of diverting ileostomy. ANZ J Surg. 2021;91(10):2115–20. pmid:34056818
  20. 20. Bhama AR, Batool F, Collins SD, Ferraro J, Cleary RK. Risk Factors for Postoperative Complications Following Diverting Loop Ileostomy Takedown. J Gastrointest Surg. 2017;21(12):2048–55. pmid:28971302
  21. 21. Zhu Y, Chen J, Lin S, Xu D. Risk factor for the development of surgical site infection following ileostomy reversal: a single-center report. Updates Surg. 2022;74(5):1675–82. pmid:36002762
  22. 22. Li LT, Brahmbhatt R, Hicks SC, Davila JA, Berger DH, Liang MK. Prevalence of surgical site infection at the stoma site following four skin closure techniques: a retrospective cohort study. Dig Surg. 2014;31(2):73–8. pmid:24776653
  23. 23. Liang MK, Li LT, Avellaneda A, Moffett JM, Hicks SC, Awad SS. Outcomes and predictors of incisional surgical site infection in stoma reversal. JAMA Surg. 2013;148(2):183–9. pmid:23426597
  24. 24. Kamada T, Ito E, Ohdaira H, Takahashi J, Takeuchi H, Kitagawa K, et al. New Scoring System for Predicting the Risk of Surgical Site Infections Following Stoma Reversal. J Surg Res. 2021;267:350–7. pmid:34198111
  25. 25. Vergara-Fernández O, Trejo-Avila M, Salgado-Nesme N. Multivariate analysis of risk factors for complications after loop ileostomy closure. CIRU. 2019;87(3):1276.
  26. 26. Chu DI, Schlieve CR, Colibaseanu DT, Simpson PJ, Wagie AE, Cima RR, et al. Surgical site infections (SSIs) after stoma reversal (SR): risk factors, implications, and protective strategies. J Gastrointest Surg. 2015;19(2):327–34. pmid:25217092
  27. 27. Pan H-D, Wang L, Peng Y-F, Li M, Yao Y-F, Zhao J, et al. Subcutaneous vacuum drains reduce surgical site infection after primary closure of defunctioning ileostomy. Int J Colorectal Dis. 2015;30(7):977–82. pmid:25700809
  28. 28. Nyandoro MG, Seow YT, Stein J, Theophilus M. Single-centre experience of loop ileostomy closure: a retrospective comparison of conventional-linear closure and purse-string closure on surgical-site-infection rates. ANZ J Surg. 2023;93(3):629–35. pmid:36197316
  29. 29. Von Savigny C, Juratli MA, Koch C, Gruber-Rouh T, Bechstein WO, Schreckenbach T. Short-term outcome of diverting loop ileostomy reversals performed by residents: a retrospective cohort prognostic factor study. Int J Colorectal Dis. 2023;38(1):108.
  30. 30. Mirande MD, McKenna NP, Bews KA, Shawki SF, Cima RR, Brady JT, et al. Risk factors for surgical site infections and trends in skin closure technique after diverting loop ileostomy reversal: A multi-institutional analysis. Am J Surg. 2023;226(5):703–8. pmid:37567817
  31. 31. Wong KS, Remzi FH, Gorgun E, Arrigain S, Church JM, Preen M. Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients. Diseases of the Colon & Rectum. 2005;48(2):243–50.
  32. 32. Ohara Y, Owada Y, Kim J, Moue S, Akashi Y, Ogawa K, et al. Clinical Benefits of Reducing Dead Space Using a Closed Suction Drain and Subcutaneous Large-bite Buried Suture Technique to Prevent Superficial Surgical-site Infections Following Primary Closure of a Diverting Stoma. J Anus Rectum Colon. 2024;8(2):70–7. pmid:38689778
  33. 33. Pokorny H, Herkner H, Jakesz R, Herbst F. Mortality and complications after stoma closure. Arch Surg. 2005;140(10):956–60.
  34. 34. Chow A, Tilney HS, Paraskeva P, Jeyarajah S, Zacharakis E, Purkayastha S. The morbidity surrounding reversal of defunctioning ileostomies: a systematic review of 48 studies including 6,107 cases. Int J Colorectal Dis. 2009;24(6):711–23. pmid:19221766
  35. 35. Carrano FM, Maroli A, Carvello M, Foppa C, Sacchi M, Crippa J, et al. Negative-pressure wound therapy after stoma reversal in colorectal surgery: a randomized controlled trial. BJS Open. 2021;5(6):zrab116. pmid:34904647
  36. 36. Wu XW, Zhang XF, Yang YY, Kang JQ, Wang PG, Wang DR. Surgical site infection after colorectal surgery in China from 2018 to 2020. Zhonghua Wei Chang Wai Ke Za Zhi. 2022;25(9):804–11.
  37. 37. Zhu J, Sun Q, Xu W, Geng J, Feng Q, Zhao Z, et al. Effect of Negative Pressure Wound Therapy on Surgical Site Infections following Stoma Reversal in Colorectal Surgery: A Meta-Analysis. J Invest Surg. 2023;36(1):2175079. pmid:36740239
  38. 38. McCartan DP, Burke JP, Walsh SR, Coffey JC. Purse-string approximation is superior to primary skin closure following stoma reversal: a systematic review and meta-analysis. Tech Coloproctol. 2013;17(4):345–51. pmid:23354904
  39. 39. Rondelli F, Franco L, Balzarotti Canger RC, Ceccarelli G, Becattini C, Bugiantella W. Purse-string closure versus conventional primary closure of wound following stoma reversal: Meta-analysis of randomized controlled trials. Int J Surg. 2018;52:208–13. pmid:29474885
  40. 40. Tilney HS, Sains PS, Lovegrove RE, Reese GE, Heriot AG, Tekkis PP. Comparison of outcomes following ileostomy versus colostomy for defunctioning colorectal anastomoses. World J Surg. 2007;31(5):1142–51. pmid:17354030
  41. 41. Uchino M, Ikeuchi H, Tsuchida T, Nakajima K, Tomita N, Takesue Y. Surgical site infection following surgery for inflammatory bowel disease in patients with clean-contaminated wounds. World J Surg. 2009;33(5):1042–8.
  42. 42. Mansfield SD, Jensen C, Phair AS, Kelly OT, Kelly SB. Complications of loop ileostomy closure: a retrospective cohort analysis of 123 patients. World J Surg. 2008;32(9):2101–6. pmid:18563482
  43. 43. O’Sullivan NJ, Temperley HC, Nugent TS, Low EZ, Kavanagh DO, Larkin JO, et al. Early vs. standard reversal ileostomy: a systematic review and meta-analysis. Tech Coloproctol. 2022;26(11):851–62. pmid:35596904
  44. 44. Ng ZQ, Levitt M, Platell C. The feasibility and safety of early ileostomy reversal: a systematic review and meta-analysis. ANZ J Surg. 2020;90(9):1580–7. pmid:32597018
  45. 45. Davis BR, Valente MA, Goldberg JE, Lightner AL, Feingold DL, Paquette IM. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Ostomy Surgery. Dis Colon Rectum. 2022;65(10):1173–90.
  46. 46. Wang L, Chen X, Liao C, Wu Q, Luo H, Yi F, et al. Early versus late closure of temporary ileostomy after rectal cancer surgery: a meta-analysis. Surg Today. 2021;51(4):463–71. pmid:32833059
  47. 47. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.
  48. 48. Mao Y, Xi L, Lu C, Miao J, Li Q, Shen X, et al. Incidence, risk factors, and predictive modeling of stoma site incisional hernia after enterostomy closure: a multicenter retrospective cohort study. BMC Gastroenterol. 2023;23(1):201. pmid:37296427
  49. 49. Gurunathan U, Ramsay S, Mitrić G, Way M, Wockner L, Myles P. Association Between Obesity and Wound Infection Following Colorectal Surgery: Systematic Review and Meta-Analysis. J Gastrointest Surg. 2017;21(10):1700–12. pmid:28785932
  50. 50. Wahl TS, Patel FC, Goss LE, Chu DI, Grams J, Morris MS. The Obese Colorectal Surgery Patient: Surgical Site Infection and Outcomes. Dis Colon Rectum. 2018;61(8):938–45. pmid:29994958
  51. 51. Teppa R, Sude NS, Karanam VPK, Mallipudi BVP. Relevance of Subcutaneous Fat Thickness as a Risk Factor for Surgical Site Infections in Abdominal Surgeries. Cureus. 2022;14(1):e20946. pmid:35004090
  52. 52. Fujii T, Tsutsumi S, Matsumoto A, Fukasawa T, Tabe Y, Yajima R, et al. Thickness of subcutaneous fat as a strong risk factor for wound infections in elective colorectal surgery: impact of prediction using preoperative CT. Dig Surg. 2010;27(4):331–5. pmid:20689296